Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

前日（2月7日）， 全球骨科手术机器人龙头企业Globus Medical（NYSE: GMED）宣布以每股5.85美元的价格收购慢性疼痛治疗公司Nevro（NYSE: NVRO）全部股份，总股权价值达2.5亿美元（约合18.2亿元人民币） 。这一价格较Nevro过去90天的平均股价溢价27%，较30天平均股价溢价38%，交易预计于2025年第二季度末完成。

Engaged Capital exited its stakes in BlackLine (NASDAQ:BL) and Nevro (NYSE:NVRO) and took a new position in Chart Industries (NYSE:GTLS) in Q4 2024, among other moves.  The hedge fund, known for its ...

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and Nevro Corp. (NYSE: NVRO), a global medical ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus will buy all outstanding Nevro shares for $5.85 per share under the terms of the agreement, therefore reflecting a 27% ...

Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

宾夕法尼亚州AUDUBON - 市值118.1亿美元、在InvestingPro获得"优秀"财务健康评级的肌肉骨骼解决方案公司Globus Medical, Inc. (NYSE: GMED)已同意以约2.5亿美元现金收购专注于慢性疼痛治疗的全球医疗设备公司Nevro Corp. (NYSE: NVRO)。根据今日宣布的收购协议，Globus ...

基于这些考虑，BTIG分析师Zimmerman重申对Globus Medical股票的买入评级，目标价为91.00美元，反映了对公司增长轨迹和Nevro Corp收购预期收益的信心。该股目前的交易价格接近52周高点94.93美元， InvestingPro 分析显示，根据其专有公允价值模型，该股票估值合理。

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Globus Medical will acquire Nevro for $250 million in cash, enhancing its musculoskeletal technology portfolio andglobal marketreach. Globus Medical and Nevro Corp. have agreed on an all-cash ...

Globus Medical (GMED) and Nevro Corp. (NVRO) have entered into a definitive agreement for Globus Medical to acquire all shares of Nevro in an ...